Back

Beyond conduction disease: a prospective screening study of transthyretin cardiac amyloidosis in older patients referred for device therapy after syncope

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Syncope and bradycardia: risk stratification, treatment and outcome Prognosis and Risk Stratification ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Carlo Fumagalli

University of Campania Luigi Vanvitell, Naples (Italy)

7 More presentations in this session

Presentation thumbnail
Long-term outcomes of single atrial lead pacing in sick sinus syndrome: risk stratification using wenckebach block rate
Ms A. Takami (Tottori, JP)
Abstract Slides
Presentation thumbnail
Incidental findings of cardiac pauses in a nationwide atrial fibrillation screening trial: Insights from the NORSCREEN trial
Mr M. Haraldsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Time to diagnosis and predictors of positive diagnostic findings in patients with unexplained syncope undergoing implantable loop recorder monitoring
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides
Presentation thumbnail
Can agentic AI match the gold standard? multi-agent risk stratification for syncope in the emergency department
Doctor A. Giaj Levra (Rozzano, IT)
Abstract Slides
Presentation thumbnail
Impact of high-power, short-duration radiofrequency ablation on first-pass binodal parasympathetic denervation during cardioneuroablation
Doctor A. Wileczek (Sanok, PL)
Abstract Slides

Access the full session

Session thumbnail
Syncope and bradycardia: risk stratification, treatment and outcome

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Transthyretin cardiac amyloidosis: what are the main clinical suspicion data?
29 June 2021
thumbnail
Congress Session
Cardiac amyloidosis uncovered: from clues to cutting-edge care
17 May 2025
thumbnail
Congress Session
Cardiomyopathies: daily clinical challenges
12 December 2025
thumbnail
Congress Presentation
Cardiovascular events in patients diagnosed with light chain amyloidosis in the USA: a real-world analysis utilizing electronic health records
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources